GI Innovation EBIT

GI Innovation (358570.KQ) currently reports a EBIT of $-44B as of June 2026. That compares with $-46B in the prior-year period — up 4.8% year over year. That is below the Healthcare sector average of $130B. Use the charts on this page to explore GI Innovation's EBIT history and peer comparisons.

GI Innovation's EBIT increased from $-46B to $-44B — a 4.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GI Innovation's EBIT of $-44B is lower than the Healthcare sector average of $130B. That is roughly 132.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

GI Innovation reported $-44B in EBIT as of June 2026. That compares with $-46B in the prior-year period — up 4.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-44B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $130B. From there, open related valuation or income-statement pages for GI Innovation, and consider following 358570.KQ for alerts when major investors trade the stock.